UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Review of trials currently testing treatment and prevention of COVID-19

Clinical microbiology and infection, 2020-08, Vol.26 (8), p.988-998

2020

Volltextzugriff (PDF)

Model Evaluation of Continuous Data Pharmacometric Models: Metrics and Graphics

CPT: pharmacometrics and systems pharmacology, 2017-02, Vol.6 (2), p.87-109

2017

Volltextzugriff (PDF)

The Use of Model-Based Tumor-Size Metrics to Predict Survival

Clinical pharmacology and therapeutics, 2014-08, Vol.96 (2), p.133-135

2014

Volltextzugriff (PDF)

Two levels of specialization in bacteraemic Escherichia coli strains revealed by their comparison with commensal strains

Epidemiology and infection, 2017-04, Vol.145 (5), p.872-882

2017

Volltextzugriff (PDF)

Mortality in Escherichia coli bloodstream infections: antibiotic resistance still does not make it

Journal of antimicrobial chemotherapy, 2020-08, Vol.75 (8), p.2334-2343

2020

Volltextzugriff (PDF)

Influence of Alpha-1 Glycoprotein Acid Concentrations and Variants on Atazanavir Pharmacokinetics in HIV-Infected Patients Included in the ANRS 107 Trial

Antimicrobial Agents and Chemotherapy, 2010-02, Vol.54 (2), p.614-619

2010

Volltextzugriff (PDF)

Bacteraemia caused by third-generation cephalosporin-resistant Escherichia coli in France: prevalence, molecular epidemiology and clinical features

Clinical microbiology and infection, 2011-04, Vol.17 (4), p.557-565

2011

Volltextzugriff (PDF)

Population pharmacokinetics and dosing simulations of amoxicillin in obese adults receiving co-amoxiclav

Journal of antimicrobial chemotherapy, 2020-12, Vol.75 (12), p.3611-3618

2020

Volltextzugriff (PDF)

High acquisition rate of extended-spectrum β-lactamase-producing Enterobacteriaceae among French military personnel on mission abroad, without evidence of inter-individual transmission

Clinical microbiology and infection, 2019-05, Vol.25 (5), p.631.e1-631.e9

2019

Volltextzugriff (PDF)

Effect of Adherence as Measured by MEMS, Ritonavir Boosting, and CYP3A5 Genotype on Atazanavir Pharmacokinetics in Treatment-Naive HIV-Infected Patients

Clinical pharmacology and therapeutics, 2012-11, Vol.92 (5), p.575-583

2012

Volltextzugriff (PDF)

Which breast cancer decisions remain non-compliant with guidelines despite the use of computerised decision support?

British journal of cancer, 2013-09, Vol.109 (5), p.1147-1156

2013

Volltextzugriff (PDF)

Population pharmacokinetic modeling of sustained release lithium in the serum, erythrocytes and urine of patients with bipolar disorder

European journal of clinical pharmacology, 2019-04, Vol.75 (4), p.519-528

2019

Volltextzugriff (PDF)

Lewis Sheiner ISoP/UCSF Lecturer Award: From Drug Use to Statistical Models and Vice Versa

CPT: pharmacometrics and systems pharmacology, 2014-12, Vol.3 (12), p.1-4

Mentré, F

2014

Volltextzugriff (PDF)

The Emergence of Linezolid Resistance among Enterococci in Intestinal Microbiota of Treated Patients Is Unrelated to Individual Pharmacokinetic Characteristics

Antimicrobial agents and chemotherapy, 2014-05, Vol.58 (5), p.2681-2687

2014

Volltextzugriff (PDF)

Determinants of macroscopic anal cancer and precancerous lesions in 1206 HIV-infected screened patients

Colorectal disease, 2016-10, Vol.18 (10), p.997-1004

2016

Volltextzugriff (PDF)

Pharmacokinetic Similarity of Biologics: Analysis Using Nonlinear Mixed-Effects Modeling

Clinical pharmacology and therapeutics, 2012-02, Vol.91 (2), p.234-242

2012

Volltextzugriff (PDF)

Escherichia coli bacteraemia in pregnant women is life-threatening for foetuses

Clinical microbiology and infection, 2014-12, Vol.20 (12), p.O1035-O1041

2014

Volltextzugriff (PDF)

The ISoP Standards and Best Practices Committee

Clinical pharmacology and therapeutics, 2014-06, Vol.95 (6), p.581-582

2014

Volltextzugriff (PDF)

A Pharmacokinetic-Viral Kinetic Model Describes the Effect of Alisporivir as Monotherapy or in Combination With Peg-IFN on Hepatitis C Virologic Response

Clinical pharmacology and therapeutics, 2014-11, Vol.96 (5), p.599-608

2014

Volltextzugriff (PDF)

Population pharmacokinetics and pharmacodynamics of imipenem in neutropenic adult patients

Infectious diseases now (Online), 2023-02, Vol.53 (1), p.104625, Article 104625

2023

Volltextzugriff (PDF)

Factors associated with clinical and virological response in patients treated with oseltamivir or zanamivir for influenza A during the 2008–2009 winter

Clinical microbiology and infection, 2013-02, Vol.19 (2), p.196-203

2013

Volltextzugriff (PDF)

Octreotide treatment of idiopathic pulmonary fibrosis: a proof-of-concept study

The European respiratory journal, 2012-03, Vol.39 (3), p.772-775

2012

Volltextzugriff (PDF)

CO1.2 - La randomisation distributive : un nouveau schéma d'essai pour l'évaluation simultanée d'interventions

Journal of Epidemiology and Population Health, 2024-05, Vol.72, p.202401, Article 202401

2024

Volltextzugriff (PDF)

CO1.2 - La randomisation distributive : un nouveau schéma d'essai pour l'évaluation simultanée d'interventions

Journal of Epidemiology and Population Health, 2024-05, Vol.72

2024

Volltextzugriff (PDF)

Powers of the Likelihood Ratio Test and the Correlation Test Using Empirical Bayes Estimates for Various Shrinkages in Population Pharmacokinetics

CPT: pharmacometrics and systems pharmacology, 2014-04, Vol.3 (4), p.1-9

2014

Volltextzugriff (PDF)

1 – 25 von 228

Suche als RSS-Feed

Aktive Filter

KollektionTaylor & Francis:Master (3349 titles)

ThemaPharmacology

ThemaPhysical Sciences

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(202)
Mit Volltextzugriff
(200)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Review of trials currently testing treatment and prevention of COVID-19

Model Evaluation of Continuous Data Pharmacometric Models: Metrics and Graphics

The Use of Model-Based Tumor-Size Metrics to Predict Survival

Two levels of specialization in bacteraemic Escherichia coli strains revealed by their comparison with commensal strains

Mortality in Escherichia coli bloodstream infections: antibiotic resistance still does not make it

Influence of Alpha-1 Glycoprotein Acid Concentrations and Variants on Atazanavir Pharmacokinetics in HIV-Infected Patients Included in the ANRS 107 Trial

Bacteraemia caused by third-generation cephalosporin-resistant Escherichia coli in France: prevalence, molecular epidemiology and clinical features

Population pharmacokinetics and dosing simulations of amoxicillin in obese adults receiving co-amoxiclav

High acquisition rate of extended-spectrum β-lactamase-producing Enterobacteriaceae among French military personnel on mission abroad, without evidence of inter-individual transmission

Effect of Adherence as Measured by MEMS, Ritonavir Boosting, and CYP3A5 Genotype on Atazanavir Pharmacokinetics in Treatment-Naive HIV-Infected Patients

Which breast cancer decisions remain non-compliant with guidelines despite the use of computerised decision support?

Population pharmacokinetic modeling of sustained release lithium in the serum, erythrocytes and urine of patients with bipolar disorder

Lewis Sheiner ISoP/UCSF Lecturer Award: From Drug Use to Statistical Models and Vice Versa

The Emergence of Linezolid Resistance among Enterococci in Intestinal Microbiota of Treated Patients Is Unrelated to Individual Pharmacokinetic Characteristics

Determinants of macroscopic anal cancer and precancerous lesions in 1206 HIV-infected screened patients

Pharmacokinetic Similarity of Biologics: Analysis Using Nonlinear Mixed-Effects Modeling

Escherichia coli bacteraemia in pregnant women is life-threatening for foetuses

The ISoP Standards and Best Practices Committee

A Pharmacokinetic-Viral Kinetic Model Describes the Effect of Alisporivir as Monotherapy or in Combination With Peg-IFN on Hepatitis C Virologic Response

Population pharmacokinetics and pharmacodynamics of imipenem in neutropenic adult patients

Factors associated with clinical and virological response in patients treated with oseltamivir or zanamivir for influenza A during the 2008–2009 winter

Octreotide treatment of idiopathic pulmonary fibrosis: a proof-of-concept study

CO1.2 - La randomisation distributive : un nouveau schéma d'essai pour l'évaluation simultanée d'interventions

CO1.2 - La randomisation distributive : un nouveau schéma d'essai pour l'évaluation simultanée d'interventions

Powers of the Likelihood Ratio Test and the Correlation Test Using Empirical Bayes Estimates for Various Shrinkages in Population Pharmacokinetics

Aktive Filter

Suchergebnisse filtern